120 related articles for article (PubMed ID: 38866110)
1. The suggestion of mitigating disparity in the liver transplantation field among ABO blood type.
Akabane M; Imaoka Y; Esquivel CO; Kim WR; Sasaki K
Am J Transplant; 2024 Jun; ():. PubMed ID: 38866110
[TBL] [Abstract][Full Text] [Related]
2. ABO-Nonidentical Liver Transplantation in the United States.
Lai JC; Roberts JP
Am J Transplant; 2016 Aug; 16(8):2430-6. PubMed ID: 26932134
[TBL] [Abstract][Full Text] [Related]
3. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
4. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.
Ge J; Roberts JP; Lai JC
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28517242
[TBL] [Abstract][Full Text] [Related]
5. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
Bernards S; Lee E; Leung N; Akan M; Gan K; Zhao H; Sarkar M; Tayur S; Mehta N
Am J Transplant; 2022 Dec; 22(12):2912-2920. PubMed ID: 35871752
[TBL] [Abstract][Full Text] [Related]
6. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Rocha-Santos V; Pinheiro RSN; Nacif LS; D'Albuquerque LAC
Transplant Proc; 2018 Apr; 50(3):754-757. PubMed ID: 29661430
[TBL] [Abstract][Full Text] [Related]
7. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
8. Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study.
Yang M; Wei X; Khan AR; Wei Q; Wang R; Pan B; Wang K; Zhou Z; Lu D; Cen B; Zhang S; Guo W; Zheng S; Yang Y; Xu X
J Clin Transl Hepatol; 2023 Aug; 11(4):827-838. PubMed ID: 37408815
[TBL] [Abstract][Full Text] [Related]
9. Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center.
Ha HS; Hong JJ; Kim IO; Lee SR; Lee AY; Ha TY; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Lee SG; Hwang S
Korean J Transplant; 2019 Dec; 33(4):112-117. PubMed ID: 35769978
[TBL] [Abstract][Full Text] [Related]
10. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
11. Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database.
Everitt MD; Donaldson AE; Casper TC; Stehlik J; Hawkins JA; Tani LY; Renlund DG; Kouretas PC; Kaza AK; Bullock EA; Cardon M; Kfoury AG
J Heart Lung Transplant; 2009 Dec; 28(12):1254-60. PubMed ID: 19782582
[TBL] [Abstract][Full Text] [Related]
12. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
13. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
14. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
15. Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD-sodium era.
Ivanics T; Leonard-Murali S; Mouzaihem H; Moonka D; Kitajima T; Yeddula S; Shamaa MT; Rizzari M; Collins K; Yoshida A; Abouljoud M; Nagai S
Transpl Int; 2021 Dec; 34(12):2856-2868. PubMed ID: 34580929
[TBL] [Abstract][Full Text] [Related]
16. Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.
Mazur RD; Cron DC; Goldberg DS; Yeh H; Dageforde LA
Clin Transplant; 2024 Jun; 38(6):e15365. PubMed ID: 38804605
[TBL] [Abstract][Full Text] [Related]
17. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
Kim WR; Mannalithara A; Kwo PY; Bonham CA; Kwong A
Hepatology; 2023 Mar; 77(3):851-861. PubMed ID: 36052665
[TBL] [Abstract][Full Text] [Related]
19. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
[TBL] [Abstract][Full Text] [Related]
20. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
